Coherus BioSciences (CHRS) Announces Patent Dance Exchange with Amgen (AMGN) for Neulasta Biosimilar
Tweet Send to a Friend
Coherus BioSciences, Inc. (Nasdaq: CHRS), announced today that it completed the initial phases of the Biologics Price Competition and Innovation ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
